Duffy antigen system

Jump to: navigation, search
Duffy antigen
Identifiers
Symbol DARC
Entrez 2532
HUGO 4035
OMIM 110700
RefSeq NM_002036
UniProt Q16570
Other data
Locus Chr. 1 q21-q22

WikiDoc Resources for Duffy antigen system

Articles

Most recent articles on Duffy antigen system

Most cited articles on Duffy antigen system

Review articles on Duffy antigen system

Articles on Duffy antigen system in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Duffy antigen system

Images of Duffy antigen system

Photos of Duffy antigen system

Podcasts & MP3s on Duffy antigen system

Videos on Duffy antigen system

Evidence Based Medicine

Cochrane Collaboration on Duffy antigen system

Bandolier on Duffy antigen system

TRIP on Duffy antigen system

Clinical Trials

Ongoing Trials on Duffy antigen system at Clinical Trials.gov

Trial results on Duffy antigen system

Clinical Trials on Duffy antigen system at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Duffy antigen system

NICE Guidance on Duffy antigen system

NHS PRODIGY Guidance

FDA on Duffy antigen system

CDC on Duffy antigen system

Books

Books on Duffy antigen system

News

Duffy antigen system in the news

Be alerted to news on Duffy antigen system

News trends on Duffy antigen system

Commentary

Blogs on Duffy antigen system

Definitions

Definitions of Duffy antigen system

Patient Resources / Community

Patient resources on Duffy antigen system

Discussion groups on Duffy antigen system

Patient Handouts on Duffy antigen system

Directions to Hospitals Treating Duffy antigen system

Risk calculators and risk factors for Duffy antigen system

Healthcare Provider Resources

Symptoms of Duffy antigen system

Causes & Risk Factors for Duffy antigen system

Diagnostic studies for Duffy antigen system

Treatment of Duffy antigen system

Continuing Medical Education (CME)

CME Programs on Duffy antigen system

International

Duffy antigen system en Espanol

Duffy antigen system en Francais

Business

Duffy antigen system in the Marketplace

Patents on Duffy antigen system

Experimental / Informatics

List of terms related to Duffy antigen system

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

The Duffy antigen system is a blood system in which a pair of proteins appears on the outside of red blood cells. It was named after the patient in which it was discovered. [1]

A person who has "Duffy negative" blood (no Duffy antigen naturally present) may be allergic, perhaps seriously allergic, to a blood transfusion which is "Duffy positive" (has this pair of proteins). Nearly all Caucasians are Duffy-positive, and a majority of those of African descent are Duffy-negative.[2] Since most Duffy-negative people are of African origin, this is one reason why encouraging blood donations from people of African origins is critically important to the health of other people of the same race.

In 1950 the Duffy antigen was discovered in a multiply transfused hemophiliac whose serum contained the first example of anti-Fya. In 1951 the antibody to a second antigen, Fyb, was discovered in the serum of a woman who had been pregnant three times. Using these antibodies three common phenotypes were defined: Fy(a+b+), Fy(a+b-), and Fy(a-b+).

Genetics and genomics

The Duffy antigen gene (gp-Fy; CD234) is located on the long arm of chromosome 1 (1.q22-1.q23) and was cloned in 1993. It is a single copy gene and encodes a 336 amino acid acidic glycoprotein. The gene carries the antigenic determinants of the Duffy blood group system consisting of four alleles - FY*A and FY*B - coding for the Fya and Fyb antigens respectively, FY*X and FY*Fy, five phenotypes (Fy-a, Fy-b, Fy-o, Fy-x and Fy-y) and five antigens. Fya and Fyb differ by in a single amino acid at position 43: aspartic acid in Fya and glycine in Fyb. The genetic basis for the Fy(a-b-) phenotype is a point mutation in the erythroid specific promoter.

The Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon. Most Duffy negative blacks carry a silent Fy-b allele with a single T to C substitution at nucleotide -46, impairing the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. The gene is still transcribed in non erythroid cells in the presence of this mutation.

Differences in the racial distribution of the Duffy antigens were discovered in 1954 when it was found that the majority of blacks had the erythrocyte phenotype Fy(a-b-): 68% in African Americans and 88-100% in African blacks (including more than 90% of West African blacks).[3] This phenotype is exceedingly rare in whites.

The mutation Ala100Thr (G -> A in the first codon position - base number 298) within the FY*B allele was thought to be purely a Caucasian genotype, but has since been described in Brazilians.[4]

This antigen along with other blood group antigens was used to identify the Basque people as a genetically separate group.[5] Its use in forensic science is under consideration.[6]

The Andaman and Nicobar Islands, now part of India, were originally inhabited by 14 aboriginal tribes. Several of these have gone extinct. One surviving tribe - the Jarawas - live in three jungle areas of South Andaman and one jungle area in Middle Andaman. The area is endemic for malaria. The causative species is Plasmodium falciparum: there is no evidence for the presence of Plasmodium vivax. Blood grouping revealed an absence of both Fy(a) and Fy(b) antigens in two areas and a low prevalence in two others.[7]

In the Yemenite Jews the frequency of the Fy allele is 0.5879.[8] The frequency of this allelle varies from 0.1083 to 0.2191 among Jews from the Middle East, North Africa and Southern Europe.

In the Chinese ethnic populations - the Han and the She people - the frequencies of Fya and Fyb alleles were 0.94 and 0.06 and 0.98 and 0.02 respectively.[9]

In Grande Comore (also known as Ngazidja) the frequency of the Fy(a- b-) phenotype is 0.86.[10]

Molecular biology

Duffy has been found to act as a multispecific receptor for chemokines of both the C-C and C-X-C families, including: melanoma growth stimulatory activity (MGSA),[11] regulated upon activation normal T expressed and secreted (RANTES; CCL5)[12] monocyte chemotatic protein-1 (MCP-1; CCL2)[13] and the angiogenic CXC chemokines interleukin-8 (IL-8, CXCL8), growth related gene alpha (GRO-α, CXCL1), neutrophil activating peptide-2 (NAP-2, CXCL7) and ENA-78 (CXCL5). Consequently the Fy protein is also known as DARC (Duffy Antigen Receptor for Chemokines). The binding site appears to be localised to the amino terminus.[14]

While Duffy is expressed on erythrocytes the Duffy antigen is found on some epithelial cells, Purkinje cells of the cerebellum,[15] endothelial cells of thyroid capillaries, the post-capillary venules of some organs[16] and the large pulmonary venules.

The antigen is predicted to have 7 transmembrane domains, an exocellular N-terminal domain and an endocellular C-terminal domain. Alignment with other seven transmembrane G-protein-coupled receptors shows that DARC lacks the highly conserved DRY motif in the second intracellular loop of the protein that is known to be associated with G-protein signaling. Consistent with this finding ligand binding by DARC does not induce G-protein coupled signal transduction nor a Ca2+ flux unlike other chemokine receptors. Based on these alignments the Duffy antigen is considered to be most similar to the interleukin-8B receptors.

On erythrocytes the Duffy antigen acts as a receptor for invasion by the human malarial parasites Plasmodium vivax and Plasmodium knowlesi; Duffy negative individuals whose erythrocytes do not express the receptor are believed to be resistant to merozoite invasion,[17] although the American journal of tropical medicine and hygiene has reported P. vivax infection in Duffy negative children in Kenya, suggesting a role in resistance to disease, not infection.[18] This antigen may also play a role in erythrocyte invasion in the rodent malarial parasite Plasmodium yoelii.

In DARC-transfected cells, DARC is internalized following ligand binding and this led to the hypothesis that expression of DARC on the surface of erythrocytes, endothelial, neuronal cells and epithelial cells may act as a sponge and provide a mechanism by which inflammatory chemokines may be removed from circulation as well as their concentration modified in the local environment.[19]

This hypothesis has also been questioned after knock out mice were created. These animals appeared healthy and had normal responses to infection. While the function of the Duffy antigen remains presently (2006) unknown, evidence is accumulating that suggests a role in neutrophil migration from the blood into the tissues[20] and in modulating the inflammatory response.[21][22][23][24][25][26][27][28][29][30] It may also play a role in the control of cancer.[31]

References

  1. Cutbush, Marie (04 February 1950). "A New Human Blood Group" (PDF). Nature (188 - 189). doi:10.1038/165188b0.  Unknown parameter |coauthors= ignored (help); Check date values in: |date= (help)
  2. Nickel RG, Willadsen SA, Freidhoff LR; et al. (1999). "Determination of Duffy genotypes in three populations of African descent using PCR and sequence-specific oligonucleotides". Hum. Immunol. 60 (8): 738–42. PMID 10439320. 
  3. Levinson, W. 2004. Medical Microbiology and Immunology. Lange Medical Books: New York. ISBN 0-07-143199-3
  4. Estalote AC, Proto-Siqueira R, Silva WA, Zago MA, Palatnik M (2005). "The mutation G298A-->Ala100Thr on the coding sequence of the Duffy antigen/chemokine receptor gene in non-caucasian Brazilians". Genet. Mol. Res. 4 (2): 166–73. PMID 16110438. 
  5. Bauduer F, Feingold J, Lacombe D (2005). "The Basques: review of population genetics and Mendelian disorders". Hum. Biol. 77 (5): 619–37. PMID 16596943. 
  6. Ferri G, Bini C, Ceccardi S, Ingravallo F, Lugaresi F, Pelotti S (2006). "Minisequencing-based genotyping of Duffy and ABO blood groups for forensic purposes". J. Forensic Sci. 51 (2): 357–60. PMID 16566771. doi:10.1111/j.1556-4029.2006.00058.x. 
  7. Das MK, Singh SS, Adak T, Vasantha K, Mohanty D (2005). "The Duffy blood groups of Jarawas - the primitive and vanishing tribe of Andaman and Nicobar Islands of India". Transfusion medicine (Oxford, England). 15 (3): 237–40. PMID 15943709. doi:10.1111/j.1365-3148.2005.00583.x. 
  8. Kobyliansky E, Micle S, Goldschmidt-Nathan M, Arensburg B, Nathan H (1980). "Duffy, Kell and P blood group systems in some Jewish populations of Israel". Acta anthropogenetica. 4 (3-4): 173–9. PMID 7346047. 
  9. Yan L, Zhu F, Fu Q, He J (2005). "ABO, Rh, MNS, Duffy, Kidd,Yt, Scianna, and Colton blood group systems in indigenous Chinese". Immunohematology / American Red Cross. 21 (1): 10–4. PMID 15783300. 
  10. Chiaroni J, Touinssi M, Frassati C; et al. (2004). "Genetic characterization of the population of Grande Comore Island (Njazidja) according to major blood groups". Hum. Biol. 76 (4): 527–41. PMID 15754970. 
  11. Horuk R, Chitnis CE, Darbonne WC; et al. (1993). "A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor". Science. 261 (5125): 1182–4. PMID 7689250. doi:10.1126/science.7689250. 
  12. Horuk R, Wang ZX, Peiper SC, Hesselgesser J (1994). "Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line". J. Biol. Chem. 269 (26): 17730–3. PMID 7517400. 
  13. Chaudhuri A, Zbrzezna V, Polyakova J, Pogo AO, Hesselgesser J, Horuk R (1994). "Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor". J. Biol. Chem. 269 (11): 7835–8. PMID 8132497. 
  14. Lu ZH, Wang ZX, Horuk R; et al. (1995). "The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain". J. Biol. Chem. 270 (44): 26239–45. PMID 7592830. 
  15. Horuk R, Martin AW, Wang Z; et al. (1997). "Expression of chemokine receptors by subsets of neurons in the central nervous system". J. Immunol. 158 (6): 2882–90. PMID 9058825. 
  16. Hadley TJ, Lu ZH, Wasniowska K; et al. (1994). "Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen". J. Clin. Invest. 94 (3): 985–91. PMID 8083383. 
  17. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976). "The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy". N. Engl. J. Med. 295 (6): 302–4. PMID 778616. 
  18. Ryan JR, Stoute JA, Amon J; et al. (2006). "Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya". Am. J. Trop. Med. Hyg. 75 (4): 575–81. PMID 17038676. 
  19. Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, Sekimizu K (2003). "A role of the Duffy antigen for the maintenance of plasma chemokine concentrations". Biochem. Biophys. Res. Commun. 303 (1): 137–9. PMID 12646177. doi:10.1016/S0006-291X(03)00293-6. 
  20. Lee JS, Frevert CW, Wurfel MM; et al. (2003). "Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo". J. Immunol. 170 (10): 5244–51. PMID 12734373. 
  21. Dawson TC, Lentsch AB, Wang Z; et al. (2000). "Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC)". Blood. 96 (5): 1681–4. PMID 10961863. 
  22. Patterson AM, Siddall H, Chamberlain G, Gardner L, Middleton J (2002). "Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium". J. Pathol. 197 (1): 108–16. PMID 12081195. doi:10.1002/path.1100. 
  23. Liu XH, Hadley TJ, Xu L, Peiper SC, Ray PE (1999). "Up-regulation of Duffy antigen receptor expression in children with renal disease". Kidney Int. 55 (4): 1491–500. PMID 10201015. doi:10.1046/j.1523-1755.1999.00385.x. 
  24. Rot A (2005). "Contribution of Duffy antigen to chemokine function". Cytokine Growth Factor Rev. 16 (6): 687–94. PMID 16054417. doi:10.1016/j.cytogfr.2005.05.011. 
  25. Segerer S, Regele H, MacK M; et al. (2000). "The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis". Kidney Int. 58 (4): 1546–56. PMID 11012889. doi:10.1046/j.1523-1755.2000.00316.x. 
  26. Segerer S, Cui Y, Eitner F; et al. (2001). "Expression of chemokines and chemokine receptors during human renal transplant rejection". Am. J. Kidney Dis. 37 (3): 518–31. PMID 11228176. 
  27. Brühl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S (2005). "Expression of DARC, CXCR3 and CCR5 in giant cell arteritis". Rheumatology (Oxford, England). 44 (3): 309–13. PMID 15572394. doi:10.1093/rheumatology/keh485. 
  28. Middleton J, Americh L, Gayon R; et al. (2005). "A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146". J. Pathol. 206 (3): 260–8. PMID 15887283. doi:10.1002/path.1788. 
  29. Segerer S, Böhmig GA, Exner M; et al. (2003). "When renal allografts turn DARC". Transplantation. 75 (7): 1030–4. PMID 12698093. doi:10.1097/01.TP.0000054679.91112.6F. 
  30. Pruenster M, Rot A (2006). "Throwing light on DARC". Biochem. Soc. Trans. 34 (Pt 6): 1005–8. PMID 17073738. doi:10.1042/BST0341005. 
  31. Zijlstra A, Quigley JP (2006). "The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel". Cancer Cell. 10 (3): 177–8. PMID 16959609. doi:10.1016/j.ccr.2006.08.012. 

External links


Linked-in.jpg